
Ceremorphic is a technology company that has developed a new architecture focused on sustainable compute infrastructure and energy-efficient AI supercomputing. Their DATACENTER-IN-BOX™ is designed to meet the growing demands of AI training and Generative AI applications. They also offer BioCompDiscoverX™, an analog and AI in silico drug design platform addressing inefficiencies in the drug development pipeline. Ceremorphic's architecture is built on proprietary multi-thread processing (ThreadArch®), quantum-resistant security, and is designed on a 3nm process. The company is actively involved in AI training supercomputing, life sciences, automotive, robotics, and metaverse processing. Founded by Dr. Venkat Mattela, who previously founded Redpine Signals (acquired by Silicon Labs for $308 million), Ceremorphic emphasizes innovation, learning, and performance.

Ceremorphic is a technology company that has developed a new architecture focused on sustainable compute infrastructure and energy-efficient AI supercomputing. Their DATACENTER-IN-BOX™ is designed to meet the growing demands of AI training and Generative AI applications. They also offer BioCompDiscoverX™, an analog and AI in silico drug design platform addressing inefficiencies in the drug development pipeline. Ceremorphic's architecture is built on proprietary multi-thread processing (ThreadArch®), quantum-resistant security, and is designed on a 3nm process. The company is actively involved in AI training supercomputing, life sciences, automotive, robotics, and metaverse processing. Founded by Dr. Venkat Mattela, who previously founded Redpine Signals (acquired by Silicon Labs for $308 million), Ceremorphic emphasizes innovation, learning, and performance.
Founded: April 2020
Headquarters: San Jose, California
Product focus: Energy-efficient AI supercomputing silicon and systems
Notable tech: ThreadArch®, Datacenter-in-Box™
Reported funding: $50M Series A (founder-funded, announced Jan 24, 2022)
| Company |
|---|
High-cost, high-energy AI training and inefficient drug discovery workflows.
2020
Computer Hardware Manufacturing
$50,000,000
Described as funded by Ceremorphic founders (founder-funded Series A announced Jan 24, 2022).
“Founder-funded $50M Series A”